MedSci Healthcare Holdings (HKSE:02415) Debt-to-EBITDA : 0.05 (As of Dec. 2023)

View and export this data going back to 2023. Start your Free Trial

What is MedSci Healthcare Holdings Debt-to-EBITDA?

Debt-to-EBITDA measures a company's ability to pay off its debt.

MedSci Healthcare Holdings's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$4.4 Mil. MedSci Healthcare Holdings's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2023 was HK$0.7 Mil. MedSci Healthcare Holdings's annualized EBITDA for the quarter that ended in Dec. 2023 was HK$113.8 Mil. MedSci Healthcare Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 was 0.04.

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt. According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

The historical rank and industry rank for MedSci Healthcare Holdings's Debt-to-EBITDA or its related term are showing as below:

HKSE:02415' s Debt-to-EBITDA Range Over the Past 10 Years
Min: -0.11 Med: 0.02 Max: 0.23
Current: 0.07

During the past 4 years, the highest Debt-to-EBITDA Ratio of MedSci Healthcare Holdings was 0.23. The lowest was -0.11. And the median was 0.02.

HKSE:02415's Debt-to-EBITDA is ranked better than
94.87% of 429 companies
in the Healthcare Providers & Services industry
Industry Median: 2.57 vs HKSE:02415: 0.07

MedSci Healthcare Holdings Debt-to-EBITDA Historical Data

The historical data trend for MedSci Healthcare Holdings's Debt-to-EBITDA can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

MedSci Healthcare Holdings Debt-to-EBITDA Chart

MedSci Healthcare Holdings Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Debt-to-EBITDA

0.23

-0.03

-0.11

0.07

MedSci Healthcare Holdings Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23
Debt-to-EBITDA	Get a 7-Day Free Trial			N/A	-	0.31	0.22	0.05

Competitive Comparison of MedSci Healthcare Holdings's Debt-to-EBITDA

For the Health Information Services subindustry, MedSci Healthcare Holdings's Debt-to-EBITDA, along with its competitors' market caps and Debt-to-EBITDA data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

MedSci Healthcare Holdings's Debt-to-EBITDA Distribution in the Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, MedSci Healthcare Holdings's Debt-to-EBITDA distribution charts can be found below:

* The bar in red indicates where MedSci Healthcare Holdings's Debt-to-EBITDA falls into.

MedSci Healthcare Holdings Debt-to-EBITDA Calculation

Debt-to-EBITDA measures a company's ability to pay off its debt.

MedSci Healthcare Holdings's Debt-to-EBITDA for the fiscal year that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(4.366	+	0.704)	/	75.554
	=	0.07

MedSci Healthcare Holdings's annualized Debt-to-EBITDA for the quarter that ended in Dec. 2023 is calculated as

Debt-to-EBITDA	=	Total Debt			/	EBITDA
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	EBITDA
	=	(4.366	+	0.704)	/	113.848
	=	0.04

In the calculation of annual Debt-to-EBITDA, the EBITDA of the last fiscal year is used. In calculating the annualized quarterly data, the EBITDA data used here is two times the quarterly (Dec. 2023) EBITDA data.

MedSci Healthcare Holdings (HKSE:02415) Debt-to-EBITDA Explanation

In the calculation of Debt-to-EBITDA, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by EBITDA. In some calculations, Total Liabilities is used to for calculation.

Be Aware

A high Debt-to-EBITDA ratio generally means that a company may spend more time to paying off its debt.

According to Joel Tillinghast's BIG MONEY THINKS SMALL: Biases, Blind Spots, and Smarter Investing, a ratio of Debt-to-EBITDA exceeding four is usually considered scary unless tangible assets cover the debt.

MedSci Healthcare Holdings Debt-to-EBITDA Related Terms

Thank you for viewing the detailed overview of MedSci Healthcare Holdings's Debt-to-EBITDA provided by GuruFocus.com. Please click on the following links to see related term pages.

MedSci Healthcare Holdings (HKSE:02415) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » MedSci Healthcare Holdings Ltd (HKSE:02415) » Definitions » Debt-to-EBITDA

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 258, Xinzhuan Road, 18th Floor, Building 34, Songjiang District, Shanghai, CHN

Website

https://ir.medsci.cn

MedSci Healthcare Holdings Ltd is an investment holding company. It operates online professional physician platforms in China. The principal activities of the Company are the provision of physician platform solutions, precision omni-channel marketing solutions, and real-world study solutions in the People's Republic of China.

Executives

Li Xinmei	2202 Interest of your spouse
Zhang Fabao	2201 Interest of corporation controlled by you
Dtx Health Limited	2101 Beneficial owner
Yu Jia	2201 Interest of corporation controlled by you
Dragon Step Ventures Limited	2101 Beneficial owner
Shanghai Qichang Investment Consulting Co., Ltd.	2201 Interest of corporation controlled by you
Suzhou Qicheng Investment Management Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Suzhou Qiming Ronghe Venture Capital Partnership (limited Partnership)	2201 Interest of corporation controlled by you
Image Frame Investment (hk) Limited
Tencent Holdings Limited
Microhealth Limited	2101 Beneficial owner
Hu Xubo	2201 Interest of corporation controlled by you
Meiyue Limited	2101 Beneficial owner

MedSci Healthcare Holdings (HKSE:02415) Headlines

No Headlines